-
Mashup Score: 1Wild-Type ATTR Amyloidosis Overview - 10 month(s) ago
Wild-Type ATTR #amyloidosis (#ATTRwt) is an age-related disease caused by transthyretin (TTR) proteins that become unstable, misfold, and build up in organs, impairing their function. Learn more about the disease and how it might affect you with our informational booklet
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
In this ARC TALKS webinar, Dr. Heather Landau discussed current treatment options for relapsed and refractory AL amyloidosis patients.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In Case You Missed It: Dr. Heather Landau discussed current treatment options for relapsed & refractory #AL #amyloidosis patients in our most recent #ARCTALKS webinar: https://t.co/6cXwYURS7h
-
-
Mashup Score: 1
The Amyloidosis Research Consortium is a nonprofit accelerating the development of and access to new and innovative treatments. We are driving the research that will have the greatest impact on length and quality of life for patients.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A diagnosis of light chain amyloidosis (#AL #amyloidosis) can be confusing and stressful, bringing up many feelings and questions. Learn more about the disease and how it might affect you with our informational booklets: https://t.co/hBGLVdcE3w
-
-
Mashup Score: 1Wild-type ATTR: Ralph's story - Amyloidosis Research Consortium - 12 month(s) ago
Ralph ‘s pain and bilateral carpal tunnel was often misdiagnosed and attributed to work related injuries until a biopsy changed things …
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Every #amyloidosis patient is different, but at ARC no patient is alone. Meet Ralph, a wild-type (#ATTRwt) patient, and hear other patients' stories through video testimonials: https://t.co/Fe1HV5uN9n
-
-
Mashup Score: 1Neuropathy in Amyloidosis - Amyloidosis Research Consortium - 1 year(s) ago
This booklet discusses the various impacts that amyloidosis may have on a patient’s nerves and potential management techniques.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It is common for patients with #amyloidosis to experience #neuropathy and in fact, some patients may have nerve-related symptoms as their most predominant sign or chief complaint. Explore the impacts that amyloidosis may have on a patient’s nerves: https://t.co/b1q4hzoS5j https://t.co/DoJynyX9wz
-
-
Mashup Score: 1Wild-type ATTR: James' story - Amyloidosis Research Consortium - 1 year(s) ago
James describes his journey to diagnosis after a stroke and month-long hospital stay. Despite his ATTRwt diagnosis, James remains optimistic.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Every #amyloidosis patient is different, but at ARC no patient is alone. Meet James, a wild-type (#ATTRwt) patient, and hear other patients' stories through video testimonials: https://t.co/p9wRL5emac
-
-
Mashup Score: 0Subscribe to our Newsletter - Amyloidosis Research Consortium - 1 year(s) ago
ARC’s newsletter is your trusted source for the latest, up-to-date amyloidosis information for HCPs, researchers, patients and caregivers …
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Subscribe to the ARC Monthly Newsletter for the latest, up-to-date #amyloidosis information for patients, caregivers, HCPs, and researchers: https://t.co/YQkjhORnkF
-
-
Mashup Score: 4Patient Resources - Amyloidosis Research Consortium - 1 year(s) ago
The Amyloidosis Research Consortium is a nonprofit accelerating the development of and access to new and innovative treatments. We are driving the research that will have the greatest impact on length and quality of life for patients.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Want to learn more about #amyloidosis on #NationalAmyloidosisDay? Don't miss all our webinars, informational booklets, patient stories, and other helpful tools in our Patient Resources: https://t.co/dXIpPUoHwl
-
-
Mashup Score: 2NIH Awards $40,000 to Amyloidosis Research Consortium (ARC) - 1 year(s) ago
The NIH has awarded the Amyloidosis Research Consortium $40,000 to support the organization’s Amyloidosis Forum meeting on June 21, 2023 …
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ARC is pushing research forward today, on #NationalAmyloidosisDay, and everyday. Our programs like the #AmyloidosisForum are a model for collaboration garnering support from the @NIH and Members of Congress like @JakeAuch: https://t.co/j1PhihIMvQ https://t.co/HjCyr2Kp9o
-
-
Mashup Score: 2NIH Awards $40,000 to Amyloidosis Research Consortium (ARC) - 1 year(s) ago
The NIH has awarded the Amyloidosis Research Consortium $40,000 to support the organization’s Amyloidosis Forum meeting on June 21, 2023 …
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We're glad to announce the @NIH has awarded the #AmyloidosisForum a grant to support our upcoming meeting in June. https://t.co/j1PhihIMvQ https://t.co/XAhK9lL46R
-
Wild-Type ATTR #amyloidosis (#ATTRwt) is an age-related disease caused by transthyretin (TTR) proteins that become unstable, misfold, and build up in organs, impairing their function. Learn more about the disease and how it might affect you: https://t.co/oAPI4jEgu8